RARITAN, NJ--(Marketwired - Jun 21, 2016) - Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, announced that its VITROS ® Immunodiagnostic Products HIV Combo Reagent Pack ...
EYSINS, SWITZERLAND and RARITAN, NJ--(Marketwired - Jun 20, 2017) - Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, and Ortho Clinical Diagnostics ("Ortho"), a global leader ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the ...
Ortho Clinical Diagnostics announced that it has received CE mark for Ortho's VITROS® XT 7600 Integrated System. By combining Ortho's proprietary dry slide technology with sophisticated digital ...
Raritan-based Ortho Clinical Diagnostics said July 9 that its VITROS Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug ...
Medical diagnostics firm Quidel Corporation plans to acquire Ortho Clinical Diagnostics, American Association for Clinical Chemistry reported March 1. The deal gives Quidel access to Ortho Clinical ...
Ortho Clinical Diagnostics (Ortho) and EKF Diagnostics (EKF) announced an agreement that allows Ortho customers to access EKF’s Stanbio Chemistry Beta-Hydroxybutyrate (BHB) LiquiColor® assay. This is ...
RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient ...
Dec 23 (Reuters) - COVID-19 test maker Quidel Corp (QDEL.O), opens new tab agreed to buy Ortho Clinical Diagnostics Holdings (OCDX.O), opens new tab for about $6 billion in a cash and stock deal, less ...
(Reuters) - Shares of private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics fell 8.8% in their Nasdaq debut on Thursday, giving the Raritan, New Jersey-based company a market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback